CME · 10-Q · 2026Q2 · Full report
Capital Return Program
CME GROUP INC. · 2026-07-24 · Importance 44 · Surprise 24 · Matches filing data
CME Group maintains authorization to repurchase up to $3.0 billion of Class A common stock through open-market, block, privately negotiated and Rule 10b5-1 transactions. Repurchase timing and amounts remain subject to market and economic conditions, share price, earnings, financial condition, capital requirements, indebtedness and legal requirements. As of June 30, 2026, $1.5 billion remained available under the authorization, which has no expiration date and may be modified, suspended or terminated.
Key facts
- We maintain a share repurchase program authorized to repurchase up to $3.0 billion of Class A common stock; maximum remaining value of shares to be repurchased was $1.5 billion as of June 30, 2026. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| cash | negative | committed | -0.7% | We maintain a share repurchase program authorized to repurchase up to $3.0 billion of Class A common stock; maximum remaining value of… |